MATRix Regimen

Preferred Label : MATRix Regimen;

NCIt synonyms : HD-MTX/HD-ARAC/Thiotepa/Rituximab; Methotrexate/Cytarabine/Thiotepa/Rituximab; Methotrexate-Cytarabine-Thiotepa-Rituximab;

NCIt related terms : MATRix; MATRix (rituximab-blit); MATRix (rituximab-pvvr); MATRix (rituximab-rixa); MATRix (rituximab-abbs); MATRix (rituximab-rite); MATRix (rituximab-rixi); MATRix (rituximab-arrx);

NCIt definition : A regimen consisting of high-dose methotrexate, high-dose cytarabine, thiotepa and rituximab that can be used in the treatment of central nervous system (CNS) lymphoma and as a conditioning regimen for autologous stem cell transplantation (ASCT).;

NCI Metathesaurus CUI : CL538288;

Codes from synonyms : 10883; 128697; 128226; 127755; 127912; 128383; 128540; 128069;

Détails

Origin ID

C140106;

UMLS CUI

C4553629;

False automatic mappings
- Matrix [EDAM data]
- Matrix [EDQM-ST unit of presentation]
- Matrix (unit of presentation) [SNOMED CT concept]
- matrix [IUPAC Term]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cytarabine [NCIt concept]
- Methotrexate [NCIt concept]
- Rituximab [NCIt concept]
- Thiotepa [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients